These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 38798554)

  • 21. The Road to CAR T-Cell Therapies for Pediatric CNS Tumors: Obstacles and New Avenues.
    Burns I; Gwynne WD; Suk Y; Custers S; Chaudhry I; Venugopal C; Singh SK
    Front Oncol; 2022; 12():815726. PubMed ID: 35155252
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Any closer to successful therapy of multiple myeloma? CAR-T cell is a good reason for optimism.
    Marofi F; Tahmasebi S; Rahman HS; Kaigorodov D; Markov A; Yumashev AV; Shomali N; Chartrand MS; Pathak Y; Mohammed RN; Jarahian M; Motavalli R; Motavalli Khiavi F
    Stem Cell Res Ther; 2021 Mar; 12(1):217. PubMed ID: 33781320
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Highlights into historical and current immune interventions for cancer.
    Cole K; Al-Kadhimi Z; Talmadge JE
    Int Immunopharmacol; 2023 Apr; 117():109882. PubMed ID: 36848790
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Neurotoxicity and management of primary and secondary central nervous system lymphoma after adoptive immunotherapy with CD19-directed chimeric antigen receptor T-cells.
    Karschnia P; Arrillaga-Romany IC; Eichler A; Forst DA; Gerstner E; Jordan JT; Ly I; Plotkin SR; Wang N; Martinez-Lage M; Winter SF; Tonn JC; Rejeski K; von Baumgarten L; Cahill DP; Nahed BV; Shankar GM; Abramson JS; Barnes JA; El-Jawahri A; Hochberg EP; Johnson PC; Soumerai JD; Takvorian RW; Chen YB; Frigault MJ; Dietrich J
    Neuro Oncol; 2023 Dec; 25(12):2239-2249. PubMed ID: 37402650
    [TBL] [Abstract][Full Text] [Related]  

  • 25. TRPM2 Channel Aggravates CNS Inflammation and Cognitive Impairment via Activation of Microglia in Chronic Cerebral Hypoperfusion.
    Miyanohara J; Kakae M; Nagayasu K; Nakagawa T; Mori Y; Arai K; Shirakawa H; Kaneko S
    J Neurosci; 2018 Apr; 38(14):3520-3533. PubMed ID: 29507145
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mechanisms of immune effector cell-associated neurotoxicity syndrome after CAR-T treatment.
    Gu T; Hu K; Si X; Hu Y; Huang H
    WIREs Mech Dis; 2022 Nov; 14(6):e1576. PubMed ID: 35871757
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immune Checkpoint Inhibition-related Neuroinflammation Disrupts Cognitive Function.
    Ifejeokwu OV; Do A; El Khatib SM; Ho NH; Zavala A; Othy S; Acharya MM
    bioRxiv; 2024 Jul; ():. PubMed ID: 39005282
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Paediatric Strategy Forum for medicinal product development of chimeric antigen receptor T-cells in children and adolescents with cancer: ACCELERATE in collaboration with the European Medicines Agency with participation of the Food and Drug Administration.
    Pearson AD; Rossig C; Mackall C; Shah NN; Baruchel A; Reaman G; Ricafort R; Heenen D; Bassan A; Berntgen M; Bird N; Bleickardt E; Bouchkouj N; Bross P; Brownstein C; Cohen SB; de Rojas T; Ehrlich L; Fox E; Gottschalk S; Hanssens L; Hawkins DS; Horak ID; Taylor DH; Johnson C; Karres D; Ligas F; Ludwinski D; Mamonkin M; Marshall L; Masouleh BK; Matloub Y; Maude S; McDonough J; Minard-Colin V; Norga K; Nysom K; Pappo A; Pearce L; Pieters R; Pule M; Quintás-Cardama A; Richardson N; Schüßler-Lenz M; Scobie N; Sersch MA; Smith MA; Sterba J; Tasian SK; Weigel B; Weiner SL; Zwaan CM; Lesa G; Vassal G
    Eur J Cancer; 2022 Jan; 160():112-133. PubMed ID: 34840026
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Systematic Evaluation of Neurotoxicity in Children and Young Adults Undergoing CD22 Chimeric Antigen Receptor T-Cell Therapy.
    Shalabi H; Wolters PL; Martin S; Toledo-Tamula MA; Roderick MC; Struemph K; Kane E; Yates B; Delbrook C; Mackall CL; Lee DW; Fry TJ; Shah NN
    J Immunother; 2018 Sep; 41(7):350-358. PubMed ID: 30048343
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Successful BCMA CAR-T Therapy for Multiple Myeloma With Central Nervous System Involvement Manifesting as Cauda Equina Syndrome-A Wandering Road to Remission.
    Wang Y; Wang L; Zeng Y; Hong R; Zu C; Yin ETS; Zhao H; Wei G; Yang L; Jin A; Hu Y; Huang H
    Front Oncol; 2021; 11():755584. PubMed ID: 34868965
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Challenges and new technologies in adoptive cell therapy.
    Zhang P; Zhang G; Wan X
    J Hematol Oncol; 2023 Aug; 16(1):97. PubMed ID: 37596653
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Chemotherapy-Induced Cognitive Impairment and Hippocampal Neurogenesis: A Review of Physiological Mechanisms and Interventions.
    Sekeres MJ; Bradley-Garcia M; Martinez-Canabal A; Winocur G
    Int J Mol Sci; 2021 Nov; 22(23):. PubMed ID: 34884513
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cellular therapy: Immune-related complications.
    Oved JH; Barrett DM; Teachey DT
    Immunol Rev; 2019 Jul; 290(1):114-126. PubMed ID: 31355491
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Role of Immunological Synapse in Predicting the Efficacy of Chimeric Antigen Receptor (CAR) Immunotherapy.
    Liu D; Badeti S; Dotti G; Jiang JG; Wang H; Dermody J; Soteropoulos P; Streck D; Birge RB; Liu C
    Cell Commun Signal; 2020 Aug; 18(1):134. PubMed ID: 32843053
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A case of successful CAR-T cell therapy for early isolated CNS recurrence of DLBCL with persistent CAR-T cells.
    Takigawa K; Kawano N; Mori Y; Yamauchi T; Tochigi T; Miyawaki K; Mori K; Shimo M; Nakaike T; Yamashita K; Mashiba K; Kikuchi I; Marutsuka K; Ohshima K; Kato K; Akashi K
    Blood Cell Ther; 2024 May; 7(2):37-40. PubMed ID: 38854403
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Transforming CLL management with immunotherapy: Investigating the potential of CAR T-cells and bispecific antibodies.
    Borogovac A; Siddiqi T
    Semin Hematol; 2024 Apr; 61(2):119-130. PubMed ID: 38290860
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Central nervous system injury from novel cancer immunotherapies.
    Winter SF; Vaios EJ; Dietrich J
    Curr Opin Neurol; 2020 Dec; 33(6):723-735. PubMed ID: 32941192
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Chimeric Antigen Receptor T Cell-Mediated Neurotoxicity in Nonhuman Primates.
    Taraseviciute A; Tkachev V; Ponce R; Turtle CJ; Snyder JM; Liggitt HD; Myerson D; Gonzalez-Cuyar L; Baldessari A; English C; Yu A; Zheng H; Furlan SN; Hunt DJ; Hoglund V; Finney O; Brakke H; Blazar BR; Berger C; Riddell SR; Gardner R; Kean LS; Jensen MC
    Cancer Discov; 2018 Jun; 8(6):750-763. PubMed ID: 29563103
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Seropositive Neuromyelitis Optica in a Case of Undiagnosed Ankylosing Spondylitis: A Neuro-Rheumatological Conundrum.
    Ghosh Md R; Roy D; León-Ruiz M; Das S; Dubey S; Benito-León J
    Qatar Med J; 2022; 2022(3):29. PubMed ID: 35864917
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Enhancing brain entry and therapeutic activity of chimeric antigen receptor T cells with intra-arterial NEO100 in a mouse model of CNS lymphoma.
    Wang W; He H; Zheng L; Zeng S; Cho HY; Kouhi A; Khawli LA; Chen L; Stathopoulos A; Schönthal AH; Epstein AL; Chen TC
    J Neurosurg; 2024 Jun; 140(6):1549-1557. PubMed ID: 38157532
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.